It has been hypothesized that inadequate placentation in the hypertensive disorder of pregnancy known as preeclampsia creates foci of placental ischemia/hypoxia leading to the elaboration of factors that compromise systemic endothelial function to produce disease sequelae. As tumor necrosis factor-␣ (TNF␣) and interleukin-1 (IL-1) are inflammatory cytokines capable of eliciting endothelial cell dysfunction, we investigated whether the production of these inflammatory cytokines by cultured villous explants from the human placenta was affected by incubation in reduced oxygen (2% O 2 ). The term placenta produced TNF␣, IL-6, and low levels of IL-1␣ and IL-1␤ under standard tissue culture conditions. Hypoxia significantly increased TNF␣, IL-1␣, and IL-1␤ production by 2-, 6-, and 23-fold, respectively, but did not affect IL-6 production. Further, cytokines were immunolocalized to the syncytiotrophoblast layer as well as to some villous core cells. Hypoxic regulation of placental TNF␣ and IL-1␤ production also appeared to differ based on gestational age. Finally, treatment with either cobalt chloride or an iron chelator mimicked the hypoxic response, suggesting that stimulation of placental cytokine production may involve a heme-containing, O 2 -sensing protein. These results suggest that placental hypoxia can lead to the elaboration of inflammatory cytokines, which may contribute to the pathophysiology of preeclampsia. (J Clin Endocrinol Metab 82: 1582-1588, 1997) P REECLAMPSIA is a disease affecting 7% of pregnancies and is clinically diagnosed by the onset of hypertension and proteinuria (1). Although the etiology of this disease is uncertain, it has been widely accepted that a defect in placental trophoblast invasion during implantation contributes to inadequate remodeling of uterine spiral arteries, thereby initiating focal regions of reduced perfusion within the placenta (2). Further, it has been suggested that a consequence of placental ischemia is the generation of cytotoxic factors that may act systemically to activate or injure the endothelium, producing the disease manifestations of preeclampsia, such as hypertension, proteinuria, and exaggerated edema (reviewed in Ref. 3). Evidence to further implicate the placental origin of this disease includes the high rate of occurrence in pregnancies with placental, but no fetal, tissue (complete hydatiform mole); the correlation between disease incidence and placental mass or multiple pregnancies; and the rapid reversal of preeclampsia after delivery (reviewed in Ref. 4) .
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The identity of deleterious factors elaborated by the placenta that presumably compromise endothelial function during preeclampsia is unknown. The inflammatory cytokines, tumor necrosis factor-␣ (TNF␣) and interleukin-1␤ (IL-1␤), are notorious for producing endothelial dysfunction (5) , and interestingly, synthesis of these cytokines, as well as IL-6, by trophoblast and other cells of the normal human placenta has been documented (6 -8) . The regulation of placental cytokine expression and, in particular, the potential impact of hypoxia are unknown. As placentas from women with preeclampsia are likely to contain ischemic foci, and the placenta has the capacity to produce inflammatory cytokines, the current investigation was designed to determine whether hypoxia further stimulates the production of inflammatory cytokines by the placenta. To this end, placental tissues were placed as explants into culture, and the elaboration of cytokines was evaluated in response to reduced O 2 .
Materials and Methods

Villous explant culture
Placentas were obtained from women undergoing elective cesarian section with normal pregnancies at term or from women undergoing elective pregnancy termination at 8 -11 gestational weeks under approval of the institutional internal review board of Magee-Women's Hospital. For term placenta, 3-5 cotelydons were extracted at random and rinsed extensively with sterile saline. Decidual tissue and large vessels were removed from villous placenta by blunt dissection. The villous tissue was then finely dissected into 5-to 10-mg pieces while in a bath of Hanks's Balanced Salt Solution (Mediatech, Herndorn, VA) containing 25 mmol/L HEPES (Sigma Chemical Co., St. Louis, MO), 10% FBS (Summit Technology, Ft. Collins, CO), and antibiotics (penicillin, streptomycin, and gentamicin, Mediatech). The pieces of tissues were then washed twice in the above solution, and 5 pieces (30 -50 mg tissue) were placed into 24-well plates (Becton Dickinson, Franklin Lakes, NJ) containing 1 mL phenol-free medium 199 (Life Technologies, Gaithersburg, MD) supplemented with 2% Nutridoma HS (Boehringer Mannheim, Indianapolis, IN) and antibiotics. First trimester villous tissue was prepared in a comparable fashion. For the culture of decidua basalis from term placenta, the basal plate was carefully trimmed from the underlying villous tissue and placed into culture as a sheet of tissue ϳ40 -70 mg/well. Explants were incubated at 37 C for a 24-h preincubation period on an orbital shaker (60 rpm) under standard tissue culture conditions of 5% CO 2 -95% room air (normoxia; 21% O 2 ). Cultures were gently shaken because it has been reported in stationary cultures of hepatoma cells maintained in 21% O 2 that the formation of an unstirred layer leads to reduced pericellular pO 2 and, consequently, elevated erythropoietin secretion (9, 10) (our unpublished results). After a me-dium change and the addition of any treatment, the plates were placed on an orbital shaker at 37 C for various times in either normoxia or reduced O 2 (hypoxia; 2.1% O 2 -5% CO 2 -92.8% N 2 ). The treatments of cobalt chloride (CoCl 2 ; 100 mol/L; Sigma) and the iron chelator Tiron (30 mmol/L; Acros, Pittsburgh, PA) were performed for a 24-h incubation period under normoxic conditions. Using a Tucker chamber and a radiometer O 2 electrode (11), the pO 2 of the hypoxic incubator was routinely determined to be 15-20 torr. At the end of the experiment, tissue weight was recorded so that cytokine values could be corrected per g wet weight, and the conditioned medium was stored at Ϫ80 C.
Jar choriocarcinoma cell culture
The trophoblast-derived human choriocarcinoma Jar cell line (American Type Culture Collection, Rockville, MD) was maintained in RPMI 1640 (Mediatech) with 10% FBS and antibiotics. Approximately 5000 cells/cm 2 were seeded in 6-well plates. After incubation for 48 h under standard culture conditions, cells were further incubated in either normoxia or hypoxia for 72 h. Conditioned medium was collected and stored at Ϫ80 C for the measurement of TNF␣, and the cell monolayer was digested in 1 n NaOH for protein determination by the Lowry method (12).
Cytokine enzyme-linked immunosorbant assays (ELISAs)
All ELISAs were performed using kits obtained from R&D Systems (Minneapolis, MN). For TNF␣ and IL-␤, high sensitivity kits were used, with sensitivities of 0.5 and 0.125 pg/mL, respectively, whereas the sensitivities for the IL-1␣ and IL-6 assays were 3.9 and 3.13 pg/mL, respectively. When sample dilution was required, either the manufacturer's serum or culture diluent, or villous explant medium was used.
L929 cytotoxicity bioassay
This bioassay is based on the cytotoxic response of actinomycin Dtreated L929 fibrosarcoma cells (American Type Culture Collection) to TNF (13) . L929 cells were seeded on 96-well plates at a density of 2.5 ϫ 10 4 cells and allowed to attach overnight. Cells were then treated for 30 -60 min with actinomycin D (10 g/mL; Sigma). Subsequently, doses of recombinant human TNF␣ (R&D) ranging from 1-500 pg/mL or 100 L conditioned medium from villous explants cultured in either normoxia or hypoxia were added to the cells. After a 24-h incubation at 37 C, a 10% Alamar blue solution (Alamar Biosciences, Sacramento, CA) was added, and fluorescence was measured at 2, 4, and 6 h (530 nm; 590 nm emission). The percent cytotoxicity was calculated as [control (untreated cells) Ϫ conditioned medium or TNF␣ standard]/control (untreated cells) ϫ 100 (%) and was plotted against the log TNF␣ concentration of the standards to interpolate TNF␣ levels of unknown samples. Immunoabsorption of TNF activity was performed by coincubation of medium samples with either goat antihuman TNF␣ neutralizing antibody (0.5 g/mL; R&D) or mouse antihuman TNF␤ monoclonal antibody (5 g/mL; PharMingen, San Diego, CA) for 1 h at 37 C before addition to the L929 bioassay. At the concentrations used, these antibodies were capable of completely neutralizing up to 200 pg/mL of the respective cytokine.
Lactate dehydrogenase (LDH) cytotoxicity assay
Assessment of explant viability was routinely monitored by measuring the release of LDH into medium relative to a 1% Triton X-100 (Sigma)-lysed positive control. The assay employed a modification of the TOX-7 viability kit supplied by Sigma and entailed adding a 20-fold volume excess of assay mixture (160 L) to the medium sample tested (8 L) . The assay mixture consisted of equal volumes of substrate (lactate), enzyme (diaphorase), and dye (nitro blue tetrazolium) solutions, and the reaction was allowed to proceed for 20 min in a microtiter plate before the addition of 0.1 vol 1 n HCl. Color change was quantified by reading the absorbance at 490 nm, and the percent cell death calculated as [OD of sample Ϫ OD of medium (background)]/(OD of Triton X-100-lysed positive control Ϫ OD of background) ϫ 100 (%), where OD is the optical density.
Immunohistochemistry
After culture, villous explant tissues were embedded in OCT compound (Baxter Scientific, McGraw Park, IL) and flash-frozen in liquid nitrogen. Twelve-micron sections were cut on a cryostat and mounted on Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA). Slides were then rinsed in Dulbecco's phosphate-buffered saline (DPBS) and fixed in 4% paraformaldehyde for 20 min at room temperature. After another DPBS wash, endogenous peroxidase activity was quenched by a 0.6% hydrogen peroxide treatment for 15 min, and then tissues were permeablized with 0.3% Triton X-100 for 10 min, followed by a DPBS wash. Immunodetection was performed using the Vectastain ABC Elite kit protocol (Vector Laboratories, Burlingame, CA). The primary antibodies were incubated with the tissue sections for 2 h at room temperature and were all monoclonal antibodies generated against the following human proteins: TNF␣ (10 -20 g/mL; clone 2C8, Biodesign, Kennebunk, ME), IL-1␤ (10 g/mL; Genzyme, Boston, MA), IL-1␣ (10 -20 g/mL; clone C12, Antigenix America, Franklin Square, NY), IL-6 (20 g/mL; Genzyme), CD68 (3.8 g/mL; Dako, Carpenteria, CA), and cytokeratin (identifies cells of epithelial origin; 3.5 g/mL; Sigma). For the negative control, the mouse IgG1 isotype (Sigma) was substituted for the primary antibody at matched concentrations. After incubation with biotinylated antimouse secondary antibody and the avidin-biotin-peroxidase complex (Vector), hydrogen peroxide and 3,3Ј-diaminobenzidine substrates (Sigma) were used to detect the peroxidase conjugate, which yielded a brown reaction product.
Data analysis
The time course of cytokine production and the response to hypoxia were analyzed by split plot design ANOVA. If significant main effects were observed, then differences between group means were assessed by orthogonal contrasts. P Ͻ 0.05 was considered to be significant. The effects of CoCl 2 and Tiron treatments were assessed by randomized block design ANOVA using Fischer's least significant difference post-hoc test. Wilcoxon's signed rank test was used to analyze fold change in hypoxic stimulation of cytokine production.
Results
Cytokine production
Under standard culture conditions, villous placental explants elaborated the inflammatory cytokines TNF␣, IL-1␤, and IL-1␣ as well as IL-6 throughout a 24-h incubation period (Fig. 1, A-D) . Both TNF␣ and IL-6 levels increased over time in culture (P Ͻ 0.05), whereas IL-1␣ and IL-1␤ production remained at low levels (Ͻ200 pg/g wet wt). Hypoxia stimulated TNF␣ production by 4 h of incubation, and TNF␣ concentrations remained elevated through the 24-h incubation period (P Ͻ 0.05; Fig. 1A) . At 10 h of incubation in the reduced O 2 environment, there was a marked stimulation of IL-1␤ production (P Ͻ 0.001; Fig. 1B) , and IL-1␣ levels were elevated by 24 h in hypoxia (P Ͻ 0.001; Fig. 1C ). In contrast, hypoxia did not affect IL-6 synthesis at any of the time points studied (Fig. 1D) . Finally, the TNF␣ produced by villous explants was bioactive, as assessed by the L929 cytotoxicity assay, and bioactivity approximated immunoreactive levels ( Table 1 ). The TNF␣ bioactivity was completely neutralized by immunoabsorption with a polyclonal antibody against human TNF␣, but was not affected by coincubation with the TNF␤ antibody (n ϭ 3; data not shown).
To determine whether the stimulation of inflammatory cytokine production by hypoxia reflected a detrimental effect of reduced O 2 on tissue viability, LDH release into the culture medium over time and in response to treatment was monitored. The percentage of cell death relative to a positive control averaged 9.5 Ϯ 1.4% at any point in culture, and there were no significant differences in LDH release between explants cultured in 21% or 2% O 2 or in response to CoCl 2 or Tiron treatment (data not shown). Finally, there was no significant difference in medium concentrations of hCG, as measured by ELISA, between explants cultured in 21% or 2% O 2 (4.2 Ϯ 0.8 vs. 4.6 Ϯ 0.8 U/mL, respectively; n ϭ 11 placentas).
Tissue localization
Localization of TNF␣, IL-1␣, IL-1␤, and IL-6 to specific cell types comprising the explanted villous tissues was documented by immunohistochemistry. For IL-1␤, slight immunoreactivity was found in the syncytiotrophoblast layer of villous explants incubated in normoxia ( Fig. 2A) , which was much more intense in tissues incubated for 24 h in hypoxia (Fig. 2B) . The syncytiotrophoblast layer was identified as cytokeratin-positive cells (Fig. 2C) . Prominent TNF␣, IL-1␣, and IL-6 immunoreactivity was also detected in the syncytiotrophoblast cell layer (data not shown); however, no obvious differences in immunoreactivity for these cytokines between tissues incubated in normoxia or hypoxia could be To further document hypoxic regulation of TNF␣ production by cells of trophoblast origin, the trophoblast-derived Jar choriocarcinoma cell line was incubated under reduced O 2 conditions. After 72 h of incubation, there was a 4-fold increase in TNF␣ levels in conditioned medium from Jar cells cultured in hypoxia compared to those in medium from cells cultured in normoxia (145.2 Ϯ 34.6 vs. 37.4 Ϯ 8.5 pg/mg protein, respectively; P Ͻ 0.05; n ϭ 4 experiments). Figure 3 depicts TNF␣ (Fig. 3A) and IL-1␤ (Fig. 3B) production by explants of villous placenta compared to that produced by decidual tissues. Although TNF␣ production after 24 h in normoxia was similar between villous and decidual explants, the responsiveness of the villous tissues to hypoxia was 2.8-fold greater than that of the decidua (P Ͻ 0.05). For IL-1␤ production, the villous placenta elaborated 7-fold more IL-1␤ into the culture medium over a 24-h incubation in normoxia compared to decidual tissues (P Ͻ 0.05); both tissues, however, responded to hypoxia with a 10-fold increase in IL-1␤ levels.
Ontogeny of regulation
Cytokine production over a 24-h culture period in normoxia as well as responsiveness to hypoxia varied according to gestational age. There was no hypoxic stimulation of either TNF␣ or IL-1␤ production by villous explants until after the ninth week of gestation, when the production of both cytokines was increased by hypoxia (P Ͻ 0.05; Fig. 4 ). In fact, TNF␣ elaboration by villous tissues obtained during weeks 8 -9 of gestation was actually reduced by 50% in response to hypoxia (P Ͻ 0.02). Of note, however, is that production of TNF␣ over 24 h in normoxia was greater for placental villi of 8 -9 gestational weeks (1776.0 Ϯ 265.3 pg/g wet wt) compared to 11 weeks (384.5 Ϯ 146.3; P Ͻ 0.02) and that TNF␣ levels produced by the 11-week gestation villi were similar to those of the term villous placental explants (refer to Fig.  1A) . IL-1␤ production after 24 h in normoxia by tissues collected at either time in the first trimester (8 weeks, 784.7 Ϯ 196.7 pg/g wet wt; 11 weeks, 752.5 Ϯ 452.3) was greater than that elaborated by the term placenta (129.2 Ϯ 24.8).
Mechanism of hypoxic stimulation
A final objective of this study was to assess whether hypoxic regulation of inflammatory cytokine production by placental tissues involved an O 2 -sensing, heme-containing protein as described in other hypoxia-sensitive systems (14) . For this study, tissues were incubated for 24 h in normoxia with and without CoCl 2 or the iron chelator, Tiron. These agents are believed to displace iron in the heme protein and thus mimic a state of reduced tissue O 2 (14, 15) . Indeed, treatment with either CoCl 2 or Tiron significantly increased TNF␣, IL-1␤, and IL-1␣ production (Fig. 5) . However, CoCl 2 increased TNF␣ production above normoxic values (22-fold) to a greater extent than either hypoxia or Tiron treatment (each 3-fold; P Ͻ 0.03; Fig. 5A ). In contrast, the stimulation of IL-1␤ synthesis by either CoCl 2 or Tiron was significantly greater than that by hypoxia (P Ͻ 0.05; Fig. 5B ), whereas the degree of stimulation of IL-1␣ synthesis was similar between CoCl 2 treatment and hypoxia (Fig. 5C) . Finally, CoCl 2 treatment resulted in a 5.5-fold stimulation of IL-6 production by villous explants (P Ͻ 0.02; data not shown), although hypoxia was without effect.
Discussion
This study demonstrated that human placental tissues in explant culture elaborate the cytokines TNF␣, IL-1␣, IL-1␤, and IL-6. Further, the production of TNF␣, IL-1␣, and IL-1␤, but not IL-6, was markedly stimulated by reduced O 2 tension. The expression of these inflammatory cytokines by the trophoblast and other cells in the normal placenta has been previously reported (6 -8, 16, 17) , and immunoreactivity was observed in the syncytiotrophoblast layer of cultured villous explants in the present study. Heightened production of TNF␣ by the trophoblast-derived Jar choriocarcinoma cells further suggests that the trophoblast cell is capable of responding to reduced O 2 with stimulated cytokine production. In addition, TNF␣ from the conditioned medium of cultured villous explants was cytotoxic in the L929 bioassay.
Only weak IL-1␤ immunoreactivity in the syncytiotrophoblast layer of term placenta has been previously reported by others (7, 16) , and no IL-1␤ messenger ribonucleic acid (mRNA) was detected in freshly isolated tissues by Northern analysis (18, 19) . However, IL-1␤ mRNA and protein could be induced in trophoblast cells using cell isolation procedures (19) . In the present study, very low levels of IL-1␤ were detected by immunohistochemistry and high sensitivity ELISA in the conditioned medium of tissues incubated in normoxia. However, IL-1␤ production was greatly stimulated by exposure to hypoxia. Therefore, it may be that at term the trophoblast produces little IL-1␤ in situ, but focal areas of placental hypoxia could serve as a potent stimulus for trophoblast IL-1␤ production.
As it is known that the maternal decidua has a relatively large population of immune cells (20) and that the decidua expresses IL-1␤ mRNA (18) and produces TNF␣ (21, 22) , it was of interest to compare the relative contributions of the maternal decidual and villous placental compartments with respect to the production of these inflammatory cytokines. When corrected for tissue weight, comparable levels of TNF␣ were produced by placental and decidual tissues over a 24-h culture period in standard O 2 conditions, whereas IL-1␤ levels were greater in the villous placenta. A previous study suggested that decidual production of TNF␣ was slightly greater than that by term chorionic villi (22) ; however, the levels reported were highly variable and were analyzed using assay procedures 500-fold less sensitive than those used in the present study. It is clear from the present results that the capacity to respond to hypoxia with elevated TNF␣ and IL-1␤ production resides primarily in the villous placental compartment. Although decidual explants produced IL-1␤ in response to hypoxia, the absolute level of production was low and may represent contamination by anchoring villi and extravillous trophoblast cells, as it is difficult to prepare term decidua completely devoid of these placental cells.
There was an interesting dichotomy in placental cytokine production dependent on gestational age, such that villous tissues collected at 8 -9 weeks gestation elaborated more TNF␣ and IL-1␤ in a 24-h culture period than the term placenta. Others have shown that TNF␣ bioactivity (22) and IL-1␤ immunoreactivity (7, 18) were greater in first trimester than term placenta. Further, IL-1␣, IL-1␤, and IL-6 mRNA levels were high in cultured cytotrophoblast cells and de- clined as the cells differentiated in vitro into syncytiotrophoblasts (23) . Thus, the greater number of villous cytotrophoblast cells in first trimester placenta could contribute to the higher cytokine levels. The ability of the villous placenta to respond to hypoxia with heightened cytokine production also appeared to be dependent on gestational age. Specifically, only placenta obtained after ϳ11 weeks gestation responded to hypoxia with elevated TNF␣ and IL-1␤ production; TNF␣ levels were actually decreased after a 24-h hypoxic incubation of villous tissues obtained at 8 weeks gestation. A recent study on the effects of hypoxia on early gestation human trophoblast differentiation demonstrates that in placenta from 10 -12 weeks gestation, hypoxic incubation inhibits cell adhesion molecule expression and cytotrophoblast invasion, but that before 7 weeks gestation, the cytotrophoblast is insensitive to hypoxic incubation in vitro (24) . Notably, before 10 -12 weeks gestation, the placental environment is relatively hypoxic in situ (18 torr) (25) , as the intervillous space is largely devoid of blood flow (26) , and after 10 -12 weeks gestation, intervillous placental blood flow begins, and pO 2 rises (25, 26) . Perhaps because the placenta from 8 -9 weeks gestation developed in a low O 2 environment in situ, hypoxic incubation ex vivo does not lead to an elevation in cytokine synthesis as it does in tissues collected after 10 weeks gestation.
The inflammatory cytokines TNF␣ and IL-1 can be included in a growing number of genes regulated by low O 2 tension (reviewed in Ref. 27 ). Incubation of human peripheral blood mononuclear cells (28) and monocytic cell lines (29) under hypoxic conditions have increased TNF␣ and IL-1␤ synthesis, and hypoxic endothelial cells in culture produce IL-1␣ (30) and IL-6 (31). Further, cerebral ischemia produced by carotid constrictures in rats leads to enhanced TNF␣ and IL-1␣ gene expression (32) , and placement of humans in hypobaric hypoxia leads to increased monocyte number and cytokine release (33) . In addition to enhanced secretion of inflammatory cytokines, low O 2 tension also increases receptors for TNF␣ and IL-1 on leukocytes (34) . In the present study, the production of TNF␣ and IL-1 by villous explants was likewise increased by hypoxia, whereas reduced O 2 failed to increase IL-6 production. However, as IL-6 levels were 3 orders of magnitude greater than those for the other inflammatory cytokines under normoxic conditions, it may be that trophoblast IL-6 production is already maximally activated.
Although several genes have been identified to be regulated by O 2 tension, the mechanisms by which O 2 levels are sensed by mammalian cells and the subsequent signaling pathways have not been completely elucidated. The classical gene to be induced by hypoxia is erythropoietin (EPO), and this hormone, which was recently found to be expressed by the human placenta (35) , has served as a model for the study of O 2 -sensing pathways (14; reviewed in Ref. 27) . From those studies, it has been hypothesized that the O 2 sensor is a heme-containing protein, because the induction of conformational changes in the heme protein to mimic a deoxygenated state, such as the irreversible displacement of the iron center by cobalt chloride or the removal of the iron center by chelation can elicit EPO production (14) . In the present study, treatment of villous explants with either CoCl 2 or the iron chelator Tiron markedly enhanced the production of inflammatory cytokines and thus mimicked the hypoxic response. However, the magnitude of this stimulatory effect on TNF␣ and IL-1␤, but not IL-1␣, expression was far greater than stimulation by hypoxia, suggesting that additional mechanisms might be activated by CoCl 2 or Tiron treatment. Further evidence in support of this contention is that incubation with zinc (ZnCl 2 ; 100 mol/L) increased villous TNF␣ production to the same extent as CoCl 2 treatment (17-fold; n ϭ 3), yet ZnCl 2 did not interact with the O 2 sensor to stimulate EPO synthesis in cultured hepatoma cells (14) (our unpublished data). As both zinc and cobalt ions are known to regulate the metallothionein gene via specific metal response elements (MRE) (36), we searched the TNF␣, IL-1␣, IL-1␤, and IL-6 gene sequences listed in GenBank for possible MRE sequences. This computer-aided analysis identified a single MRE consensus sequence (CT.CGCCC) (37) in the human TNF␣ gene 15 bp upstream from the start site, but not in the IL-1␣, IL-1␤, or IL-6 sequences screened. Thus, other mechanisms may be involved in the stimulation of cytokine production by metals.
In conclusion, the results of this study demonstrate that reduced O 2 stimulates placental production of the inflammatory cytokines TNF␣, IL-1␣, and IL-1␤. Besides its effects on cytokine synthesis, hypoxic incubation of placental tissues has also been shown to promote hyperplasia of the villous cytotrophoblast stem cell layer (24, 38, 39) and to attenuate the programmed expression of the cell adhesion markers required for appropriate trophoblast invasion (24) . These effects of hypoxia in vitro mimic some of the pathologies documented in placenta from preeclamptic women (40, 41) . If another consequence of uteroplacental ischemia in vivo is elevated placental cytokine production, as suggested by this study, then the chronic overproduction of inflammatory cytokines may be capable of eliciting detrimental effects on the maternal systemic endothelium that most likely mediate the disease manifestations of preeclampsia.
